Gentel Bioscience Licenses PriTest Technology

Protein microarray life sciences company Gentel Biosciences Inc. of Madison, Wis., has obtained an exclusive global license from PriTest Inc. of Redmond, Wash., a tuberculosis and microbial testing solution provider. The license will cover arrays using a translucent nitrocellulose surface and will build on the former company’s position in the field of protein microarrays.





LATEST NEWS

• AmeriCOM Adds President and CEO: People in the News: 5/1/24
  May 1, 2024
• Machine Learning Pushes High-Power Lasing Limits
  May 1, 2024
• IPG Names Industry Veteran Mark Gitin CEO
  Apr 30, 2024
• 16th Biannual Optatec Conference Continues in Frankfurt
  Apr 30, 2024
• Celestial Surface Mapping Tech Combines Established Techniques
  Apr 30, 2024
• TSMC Partnerships Target Integrated Photonics Capabilities
  Apr 30, 2024
• CLEO Heads to the East Coast
  Apr 29, 2024
• Qubits Could be Stored in Flash-Like Memory
  Apr 29, 2024